Publications (2)18.83 Total impact
-
Article: Response to alemtuzumab in FIP1L1/PDGFRA-negative hypereosinophilic myocarditis on serial cardiac magnetic resonance imaging.
Journal of the American College of Cardiology 01/2012; 59(4):430. · 14.16 Impact Factor -
Article: Treatment-refractory idiopathic hypereosinophilic syndrome: pitfalls and progress with use of novel drugs.
American Journal of Hematology 01/2012; 87(7):703-6. · 4.67 Impact Factor
Top Journals
Institutions
-
2012
-
Mayo Foundation for Medical Education and Research
- Division of Hematology
Scottsdale, AZ, USA
-